Frequency of the MTHFR C677T Polymorphism in Yemeni Children with Sickle Cell Disease

REFERENCES

• McCully KS. Homocysteine, vitamins, and vascular disease prevention. Am J Clin Nutr 2007;86(5):1563S–1568S.
   PubMed Web of Science ®Google Scholar
• Schnog JB, Van der Dijs FPL, Brouwer DAJ, Duits AJ, Muskiet FD, Muskiet FAJ. Plasma homocysteine levels in sickle cell disease and the need for folate supplementation. J Pediatr Hematol Oncol 2000;22(2):184–185.
   PubMed Web of Science ®Google Scholar
• Castro R, Rivera I, Blom HJ, Jakobs C, Tavares de Almeida I. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis 2006;29(1):3–20.
   PubMed Web of Science ®Google Scholar
• Goyette P, Sumner JS, Milos R, Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 1994;7(2):195–200.
   PubMed Web of Science ®Google Scholar
• Kang SS, Kong PWK, Zhou J, Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism 1988;37(7):611–613.
   PubMed Web of Science ®Google Scholar
• Frosst P, Blom HJ, Milos R, A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10(1):111–113.
   PubMed Web of Science ®Google Scholar
• Jacques PF, Bostom AG, Williams RR, Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93(1):7–9.
   PubMed Web of Science ®Google Scholar
• Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001;22(4):195–201.
   PubMed Web of Science ®Google Scholar
• Wilcken B, Bamforth F, Li Z, Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 2003;40(8):619–625.
   PubMed Web of Science ®Google Scholar
• Malinow MR, Nieto FJ, Kruger WD, The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 1997;17(6):1157–1162.
   PubMed Web of Science ®Google Scholar
• Clarke R. Dose-dependent effects of folic acid on blood concentrations of homocysteine: A meta-analysis of the randomized trials. Am J Clin Nutr 2005;82(4):806–812.
   PubMed Web of Science ®Google Scholar
• Ballas SK, Saidi P. Thrombosis, megaloblastic anaemia, and sickle cell disease: A unified hypothesis [7]. Br J Haematol 1997;96(4):879–80.
   PubMed Web of Science ®Google Scholar
• van der Dijs FP, Schnog JJ, Brouwer DA, Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients. Am J Hematol 1998;59(3):192–198.
   PubMed Web of Science ®Google Scholar
• Balasa VV, Kalinyak KA, Bean JA, Stroop D, Gruppo RA. Hyperhomocysteinemia is associated with low plasma pyridoxine levels in children with sickle cell disease. J Pediatr Hematol Oncol 2002;24(5):374–379.
   PubMed Web of Science ®Google Scholar
• Houston PE, Rana S, Sekhsaria S, Perlin E, Kim KS, Castro OL. Homocysteine in sickle cell disease: relationship to stroke. Am J Med 1997;103(3):192–196.
   PubMed Web of Science ®Google Scholar
• Kutlar A, Kutlar F, Turker I, Tural C. The methylene tetrahydrofolate reductase (C677T) mutation as a potential risk factor for avascular necrosis in sickle cell disease. Hemoglobin 2001;25(2):213–217.
   PubMed Web of Science ®Google Scholar
• Moreira Neto F, Lourenco DM, Noguti MA, The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease. Braz J Med Biol Res 2006;39(10):1291–1295.
   PubMed Web of Science ®Google Scholar
• Zimmerman SA, Ware RE. Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Am J Hematol 1998;59(4):267–272.
   PubMed Web of Science ®Google Scholar
• Adekile AD, Kutlar F, Haider MZ, Kutlar A. Frequency of the 677 C→T mutation of the methylenetetrahydrofolate reductase gene among Kuwaiti sickle cell disease patients. Am J Hematol 2001;66(4):263–266.
   PubMed Web of Science ®Google Scholar
• Driscoll MC, Prauner R. The methylenetetrahydrofolate reductase gene C677T mutant and ischemic stroke in sickle cell disease. Thromb Haemost 1999;82(6):1780–1781.
   PubMed Web of Science ®Google Scholar
• Cumming AM, Olujohungbe A, Keeney S, Singh H, Hay CR, Serjeant GR. The methylenetetrahydrofolate reductase gene C677T polymorphism in patients with homozygous sickle cell disease and stroke. Br J Haematol 1999;107(3):569–571.
   PubMed Web of Science ®Google Scholar
• Romana M, Muralitharan S, Ramasawmy R, Nagel RL, Krishnamoorthy R. Thrombosis-associated gene variants in sickle cell anemia. Thromb Haemost 2002;87(2):356–358.
   PubMed Web of Science ®Google Scholar
• Balasa VV, Gruppo RA, Gartside PS, Kalinyak KA. Correlation of the C677T MTHFR genotype with homocysteine levels in children with sickle cell disease. J Pediatr Hematol Oncol 1999;21(5):397–400.
   PubMed Web of Science ®Google Scholar
• Andrade FL, Annichino-Bizzacchi JM, Saad ST, Costa FF, Arruda VR. Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil. Am J Hematol 1998;59(1):46–50.
   PubMed Web of Science ®Google Scholar
• Al-Saqladi A, Delpisheh A, Bin-Gadeem H, Brabin BJ. Clinical profile of sickle cell disease in Yemeni children. Ann Trop Paediatr 2007;27(4):253–259.
   PubMed Web of Science ®Google Scholar
• Gill FM, Sleeper LA, Weiner SJ, Clinical events in the first decade in a cohort of infants with sickle cell disease. Blood 1995;86(2):776–783.
   PubMed Web of Science ®Google Scholar
• El-Hazmi MA. Clinical and haematological diversity of sickle cell disease in Saudi children. J Trop Pediatr 1992;38(3):106–112.
   PubMed Web of Science ®Google Scholar
• Al-Saqladi A, Delpisheh A, Bin-Gadeem H, Brabin BJ. Severity of sickle cell disease in Yemeni children. J Trop Pediatr 2009; in press.
   PubMed Web of Science ®Google Scholar
• El-Hazmi MA, Bahakim HM, Warsy AS, Does Gγ/Aγ ratio and Hb F level influence the severity of sickle cell anaemia. Mol Cell Biochem 1993;124(1):17–22.
   PubMed Web of Science ®Google Scholar
• Rasmussen K, Moller J. Total homocysteine measurement in clinical practice. Ann Clin Biochem 2000;37(5):627–648.
   PubMedGoogle Scholar
• Soldin OP, Dahlin JR, Gresham EG, King J, Soldin SJ. IMMULITE 2000 age and sex-specific reference intervals for α fetoprotein, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3, C-peptide, immunoglobulin E and intact parathyroid hormone. Clin Biochem 2008;41(12):937–942.
   PubMed Web of Science ®Google Scholar
• Al-Absi IK, Al-Subaie AM, Ameen G, Association of the methylenetetrahydrofolate reductase A1298C but not the C677T single nucleotide polymorphism with sickle cell disease in Bahrain. Hemoglobin 2006;30(4):449–453.
   PubMed Web of Science ®Google Scholar
• Schneider JA, Rees DC, Liu YT, Clegg JB. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet 1998;62(5):1258–1260.
   PubMed Web of Science ®Google Scholar
• Fawaz NA, Bashawery L, Al-Sheikh I, Qatari A, Al-Othman SS, Almawi WY. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia. Am J Hematol 2004;76(3):307–309.
   PubMed Web of Science ®Google Scholar
• Segal JB, Miller ER3rd, Brereton NH, Resar LMS. Concentrations of B vitamins and homocysteine in children with sickle cell anemia. South Med J 2004;97(2):149–155.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Cortes HM, Griener JC, Hyland K, Plasma homocysteine levels and folate status in children with sickle cell anemia. J Pediatr Hematol Oncol 1999;21(3):219–223.
   PubMed Web of Science ®Google Scholar
• Muskiet FA, van der Dijs FP, Fokkema MR, Muskiet FD. Erythrocyte folate does not accurately reflect folate status in sickle cell disease. Clin Chem 2000;46(12):2015–2016.
   PubMed Web of Science ®Google Scholar
• Schnog JB, Van der Dijs FP, Fokkema MR, Muskiet FD, Muskiet FA. Folate status assessment and folic acid supplements in sickle cell disease. J Pediatr Hematol Oncol 2001;23(8):548.
   PubMed Web of Science ®Google Scholar
• Guttormsen AB, Ueland PM, Nesthus I, Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 μmol/L). The Hordaland Homocysteine Study. J Clin Invest 1996;98(9):2174–2183.
   PubMed Web of Science ®Google Scholar
• Hustad S, Midttun O, Schneede J, Vollset SE, Grotmol T, Ueland PM. The methylenetetrahydrofolate reductase 677C→T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism. Am J Hum Genet 2007;80(5):846–855.
   PubMed Web of Science ®Google Scholar
• Moriyama Y, Okamura T, Kajinami K, Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis 2002;164(2):321–328.
   PubMed Web of Science ®Google Scholar
• Ashfield-Watt PAL, Pullin CH, Whiting JM, Methylenetetrahydrofolate reductase 677C→T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nutr 2002;76(1):180–186.
   PubMed Web of Science ®Google Scholar
• Ulvik A, Ueland PM, Fredriksen A, Functional inference of the methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms from a large-scale epidemiological study. Hum Genet 2007;121(1):57–64.
   PubMed Web of Science ®Google Scholar